AR095150A1 - Combinación farmacéutica oral, útil para restablecer alteraciones de la función intestinal y proceso para prepararla - Google Patents
Combinación farmacéutica oral, útil para restablecer alteraciones de la función intestinal y proceso para prepararlaInfo
- Publication number
- AR095150A1 AR095150A1 ARP140100374A ARP140100374A AR095150A1 AR 095150 A1 AR095150 A1 AR 095150A1 AR P140100374 A ARP140100374 A AR P140100374A AR P140100374 A ARP140100374 A AR P140100374A AR 095150 A1 AR095150 A1 AR 095150A1
- Authority
- AR
- Argentina
- Prior art keywords
- lactobacillus
- pharmaceutical combination
- bifido
- bacillus
- useful
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La combinación farmacéutica oral es útil para restablecer alteraciones de la función intestinal y comprende cantidades terapéuticamente efectivas de un principio activo para el tratamiento de los distintos trastornos funcionales gastrointestinales y de un probiótico junto a excipientes farmacéuticamente aceptables. El principio puede comprender trimebutina, cinitaprida, propinox, lansoprazol, esomeprazol, dexlansoprazol, ranitidina, famotidina, cimetidina o propinox combinado con clonixinato de lisina. El probiótico puede comprender una cepa bacteriana seleccionada entre Bifido-bacterias sp, Lactobacilos sp, Bacilos sp, Lactococos, Estreptococos sp, Enterococos y Levaduras, tales como Bifido-bacterium breve o brevis, Bifidobacterium lactis, Bifido-bacterium longum, Bifidobacterium animalis, Lactobacillus acidophilus, Lactobacillus Reuteri, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus fermentum, Lactobacillus johnsonii, Lactobacillus helveticus, Lactobacillus delbrueckii, Bacilos Subtilis, Bacilos Clausii, Streptococcus thermophilus, Streptococcus faecium, Streptococcus faecalis, Enterococos fecalis, Bacillus coagulans, Propionibacterium freudenreichii y Sacaromyces Boulardi, en un intervalo entre 1 x 10³ UFC y 1 x 10¹⁴ UFC por unidad de dosificación. La combinación farmacéutica puede incluir una cantidad terapéuticamente efectiva de un nutracéutico seleccionado entre un prebiótico, una vitamina o un mineral.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2013002737A MX2013002737A (es) | 2013-03-11 | 2013-03-11 | Combinaciones con probioticos para restablecer alteraciones de la funcion intestinal. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095150A1 true AR095150A1 (es) | 2015-09-30 |
Family
ID=51535962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140100374A AR095150A1 (es) | 2013-03-11 | 2014-02-04 | Combinación farmacéutica oral, útil para restablecer alteraciones de la función intestinal y proceso para prepararla |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR095150A1 (es) |
| BR (1) | BR112015022146A2 (es) |
| MX (1) | MX2013002737A (es) |
| UY (1) | UY35378A (es) |
| WO (1) | WO2014141075A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11986501B2 (en) * | 2018-07-16 | 2024-05-21 | Unm Rainforest Innovations | Treatment methods and compositions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20110679A1 (it) * | 2011-04-20 | 2012-10-21 | Giovanni Mogna | Composizione comprendente batteri probiotici in grado di ripristinare l effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell iperacidita gastrica. |
| US9579353B2 (en) * | 2011-06-10 | 2017-02-28 | Prothera, Inc. | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes |
-
2013
- 2013-03-11 MX MX2013002737A patent/MX2013002737A/es unknown
-
2014
- 2014-02-04 AR ARP140100374A patent/AR095150A1/es unknown
- 2014-03-10 UY UY0001035378A patent/UY35378A/es unknown
- 2014-03-11 WO PCT/IB2014/059639 patent/WO2014141075A1/es active Application Filing
- 2014-03-11 BR BR112015022146A patent/BR112015022146A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014141075A1 (es) | 2014-09-18 |
| MX2013002737A (es) | 2014-09-22 |
| BR112015022146A2 (pt) | 2017-07-18 |
| UY35378A (es) | 2014-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2017127597A (ru) | Применение короткоцепочечных жирных кислот для профилактики рака | |
| PH12018502042A1 (en) | Use of probiotics in the treatment and/or prevention of psoriasis | |
| RU2007106038A (ru) | Композиция на основе пробиотических бактерий и ее применение в профилактике и/или лечении респираторных патологий и/или инфекций и в улучшении функции кишечника | |
| JP2018504457A5 (es) | ||
| NZ744342A (en) | Probiotics for use as anti-inflammatory agents in the oral cavity | |
| RU2018120843A (ru) | Композиция кормовой добавки | |
| RU2011106319A (ru) | Пробиотики для увелечения секреции iga у младенцев, рожденных посредством кесарева сечения | |
| JP2013507394A5 (es) | ||
| PH12019500123A1 (en) | Use of probiotics in the treatment and/or prevention of atopic dermatitis | |
| PH12018502406A1 (en) | Nutritional composition comprising a probiotic for the prevention and/or treatment of anxiety disorders and related conditions in a mammal | |
| RU2013126599A (ru) | Нереплицирующиеся пробиотические микроорганизмы, защищающие против инфекций верхних дыхательных путей | |
| JP2016524900A5 (es) | ||
| RU2014107770A (ru) | Композиция, содержащая n-ацетилцистеин и/или микроинкапсулированный защищенный от действия желудочного сока лизоцим в сочетании с пробиотическими бактериями, способная восстанавливать собственный барьерный эффект желудка, который утрачивается во время фармалогического лечения желудочной гиперацидности | |
| RU2013151611A (ru) | Композиция, содержащая пробиотические бактерии, способная восстанавливать барьерный эффект желудка, утраченный в процессе фармакологического лечения повышенной кислотности желудка | |
| JP2012110334A5 (es) | ||
| FI3016667T3 (fi) | Probioottisia bakteerikantoja suuontelon sairauksien ehkäisemiseen ja hoitamiseen | |
| RU2013126616A (ru) | Замороженные кондитерские изделия, содержащие пробиотические микроорганизмы | |
| RU2011150216A (ru) | Детские питательные смеси, содержащие пробиотические микроорганизмы | |
| RU2019116519A (ru) | Композиция для направленной доставки биологически активного компонента в толстую кишку и ее применение | |
| RU2013126609A (ru) | Экструдированные нереплицирующиеся пробиотические микроорганизмы и их польза для здоровья | |
| IT201600127498A1 (it) | Probiotici per uso nella diverticolosi e malattia diverticolare | |
| JP2017513906A5 (es) | ||
| HRPK20130487B3 (hr) | Formulacija probiotika s apigeninom i ekstraktom paprene metvice | |
| RU2018139655A (ru) | Бифидобактерии для увеличения безжировой массы тела | |
| MX2017007654A (es) | Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |